Grace Sells Chromatography Product Line

News
Article

W.R. Grace & Co. will sell its chromatography product lines, which includes chromatography instruments, columns, and other related products.

W.R Grace & Co announced on May 23, 2016 that it will sell product lines associated with its chromatography instruments, columns, and related laboratory products businesses. The company said it plans to focus on its pharmaceutical and nutraceutical business. According to a press announcement, Grace will continue to supply Vydac and Davisil media for process chromatography, Syloid FP excipients for drug formulations, and custom manufacturing of regulatory starting materials and intermediates.

The company said that it will sell its flash chromatography and ELSD instrument business to BUCHI Corporation, a division of BUCHI Labortechnik AG, a Swiss manufacturer and supplier of laboratory equipment. The sale includes Reveleris purification systems, GraceResolv and Reveleris Flash Cartridges, and Alltech ELSD 3300 instrumentation.

Dr. Maisch GmBH, a German company focusing on high-performance liquid chromatography (HPLC), will purchase Grace’s line of analytical HPLC columns, preparative columns, and packing equipment and services. This includes Exsil, Modsil, and Exmere Media, the Alltech HPLC column brands Adsorbosphere, Allsphere, Brava, Econophere, Gracesmart, Platinum, and Visionht brands. Also included is the ModCol brand including Spring Preparative Column Hardware, Multipacker packing equipment ad packing services.

Hichrom Ltd. will acquire Grace’s Vydac column brand, in addition to the Alltima, Allsep, Apex, Apollo, Genesis, and Prevail HPLC column brands. The Grace and Alltech solid phase extraction cartridge brands Maxi-Clean, Extract-Clean, and Gracepure will be acquired by S*Pure Pte Ltd., a laboratory equipment supplier based in Singapore.

Source: Grace

 

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content